Related Experiment Video
Updated: Jul 8, 2026

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
Published on: January 12, 2024
Is eczema really on the increase worldwide?
Hywel Williams1, Alistair Stewart, Erika von Mutius
1Centre of Evidence-Based Dermatology, University of Nottingham, Nottingham, United Kingdom. hywel.williams@nottingham.ac.uk
Insights
Worldwide childhood eczema prevalence is leveling or decreasing in some developed nations but increasing in many developing countries, particularly among younger children. This trend indicates a complex global shift in eczema epidemiology.
Area of Science:
- Epidemiology
- Pediatrics
- Dermatology
Background:
- Global prevalence of childhood eczema remains uncertain.
- Investigating secular trends is crucial for understanding disease patterns.
Purpose of the Study:
- To examine worldwide trends in childhood eczema prevalence.
- To analyze changes over time in different global regions and age groups.
Main Methods:
- Utilized data from the International Study of Asthma and Allergies in Childhood (ISAAC) Phases One and Three.
- Surveyed over 490,000 children aged 6-7 and 13-14 years across 105 centers in 55 countries using validated questionnaires.
- Defined eczema as an itchy, relapsing, flexural rash and severe eczema by sleep disturbance.
Main Results:
- Eczema prevalence changes varied by age and region.
- In 13-14 year olds, prevalence decreased in some developed countries but increased in developing countries.
- Most 6-7 year olds showed increased eczema symptoms, with similar patterns for severe eczema.
Conclusions:
- Childhood eczema epidemic appears to be stabilizing or declining in some high-prevalence developed countries.
- Many developing countries are experiencing significant increases in eczema, especially in younger children.
- Global eczema trends are complex and regionally diverse.
Background:
It is unclear whether eczema prevalence is truly increasing worldwide.
Objective:
We sought to investigate worldwide secular trends in childhood eczema.
Methods:
Children (n = 302,159) aged 13 to 14 years in 105 centers from 55 countries and children aged 6 to 7 years (n = 187,943) in 64 centers from 35 countries were surveyed from the same study centers taking part in Phase One and Three of the International Study of Asthma and Allergies in Childhood by using identical validated and translated questionnaires. Eczema was defined as an itchy, relapsing, flexural skin rash in the last 12 months, and it was termed severe eczema when it was associated with 1 or more disturbed nights per week.
Results:
Annual prevalence changes in relation to average prevalence across Phase One and Three were generally small and differed in direction according to the age of the participants and world region. For children 13 to 14 years old, eczema symptom prevalence decreased in some previously high-prevalence centers from the developed world, such as the United Kingdom and New Zealand, whereas centers with previously high prevalence rates from developing countries continued to increase. In the children 6 to 7 years old, most centers showed an increase in current eczema symptoms. Similar patterns to these were present for severe eczema at both ages.
Conclusion:
The epidemic of eczema seems to be leveling or decreasing in some countries with previously high prevalence rates. The picture elsewhere is mixed, with many formerly low-prevalence developing countries experiencing substantial increases, especially in the younger age group.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Asthma I: Introduction
Asthma-I: Introduction
Acne Infection
Global Climate Change
Asthma III: Clinical Manifestations